Affiliations: [a]
Hull York Medical School, Heslington, UK
| [b] Cumberland Infirmary, Carlisle, UK
| [c]
Sidra Medical and Research Center, Doha, Qatar
Correspondence:
[*]
Corresponding author: SW Lindow, Division of Obstetrics, Sidra Medical and Research Center. PO Box 26999, Doha, Qatar. Tel.: +974 4012 5807; slindow@sidra.org
Abstract: BACKGROUND:Placenta accreta is a condition of abnormal placental attachment that was usually treated by hysterectomy. Techniques to conserve the uterus are now commonly used and series of subsequent pregnancy outcomes have been reported. The recurrence risk of placenta accreta is now a relevant detail and is currently not known. This work was performed to calculate the recurrence risk by reviewing the published literature. METHODS:A literature search using the terms “placenta accreta”, “placenta percreta”, “placenta increta”, “abnormal placental attachment” and “placental attachment disorder” followed by hand-searching identified 6 papers that contained data concerning recurrence of placenta accreta in subsequent pregnancies following initial conservative treatment. RESULTS:Overall 407 pregnancies were recorded and 85.7% of women reported achieved a subsequent pregnancy following conservative treatment. The risk of recurrence of placental attachment disorder in a subsequent pregnancy was 19.9% (weighted mean, 95% CI 12.2–27.7). CONCLUSIONS:The recurrence risk of placental attachment disorder following uterine conservation treatments is 20% . This risk should be discussed with women with an antenatal diagnosis of a placental attachment disorder who may be considering uterine conservation in order to retain the option of a future pregnancy.
